Halozyme Therapeutics Inc. sell SVB Leerink LLC
Start price
13.05.25
/
50%
€48.64
Target price
13.05.26
€42.31
Performance (%)
14.88%
Price
17:31
€55.88
Summary
This prediction is currently active. The SELL prediction by SVB_Leerink_LLC currently has a performance of 14.88%. This prediction currently runs until 13.05.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 4.630% | 4.630% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) was downgraded by analysts at Leerink Partners from a "market perform" rating to an "underperform" rating. They now have a $47.00 price target on the stock.
Ratings data for HALO provided by MarketBeat